Patent Expiration Date : 2028-11-09
DASABUVIR SODIUM; OMBITASVIR, PARITAPREVIR, RITONAVIR
US Patent Number : 9139536
Drug Substance Claim :
Drug Product Claim :
Application Number : 206619
Patent Use Code : U-1753
Delist Requested :
Patent Use Description : TREATMENT OF HCV INFEC...
Patent Expiration Date : 2028-11-09
Patent Expiration Date : 2032-09-04
DASABUVIR SODIUM; OMBITASVIR, PARITAPREVIR, RITONAVIR
US Patent Number : 8466159
Drug Substance Claim :
Drug Product Claim :
Application Number : 206619
Patent Use Code : U-1637
Delist Requested :
Patent Use Description : TREATMENT OF HCV INFEC...
Patent Expiration Date : 2032-09-04
Patent Expiration Date : 2028-12-19
DASABUVIR SODIUM; OMBITASVIR, PARITAPREVIR, RITONAVIR
US Patent Number : 8501238
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 206619
Patent Use Code : U-1636
Delist Requested :
Patent Use Description : USE OF DASABUVIR TO IN...
Patent Expiration Date : 2028-12-19
Patent Expiration Date : 2033-10-18
DASABUVIR SODIUM; OMBITASVIR, PARITAPREVIR, RITONAVIR
US Patent Number : 9629841
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 206619
Patent Use Code : U-1753
Delist Requested :
Patent Use Description : TREATMENT OF HCV INFEC...
Patent Expiration Date : 2033-10-18
Patent Expiration Date : 2029-09-10
DASABUVIR SODIUM; OMBITASVIR, PARITAPREVIR, RITONAVIR
US Patent Number : 8642538
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 206619
Patent Use Code : U-1638
Delist Requested :
Patent Use Description : TREATMENT OF HCV INFEC...
Patent Expiration Date : 2029-09-10
Patent Expiration Date : 2032-09-04
DASABUVIR SODIUM; OMBITASVIR, PARITAPREVIR, RITONAVIR
US Patent Number : 8680106
Drug Substance Claim :
Drug Product Claim :
Application Number : 206619
Patent Use Code : U-1637
Delist Requested :
Patent Use Description : TREATMENT OF HCV INFEC...
Patent Expiration Date : 2032-09-04
Patent Expiration Date : 2030-06-10
DASABUVIR SODIUM; OMBITASVIR, PARITAPREVIR, RITONAVIR
US Patent Number : 9006387
Drug Substance Claim :
Drug Product Claim :
Application Number : 206619
Patent Use Code : U-1687
Delist Requested :
Patent Use Description : TREATMENT OF HCV INFEC...
Patent Expiration Date : 2030-06-10
Patent Expiration Date : 2032-09-04
DASABUVIR SODIUM; OMBITASVIR, PARITAPREVIR, RITONAVIR
US Patent Number : 8685984
Drug Substance Claim :
Drug Product Claim :
Application Number : 206619
Patent Use Code : U-1840
Delist Requested :
Patent Use Description : TREATMENT OF HCV INFEC...
Patent Expiration Date : 2032-09-04
Patent Expiration Date : 2032-09-04
DASABUVIR SODIUM; OMBITASVIR, PARITAPREVIR, RITONAVIR
US Patent Number : 8492386
Drug Substance Claim :
Drug Product Claim :
Application Number : 206619
Patent Use Code : U-1840
Delist Requested :
Patent Use Description : TREATMENT OF HCV INFEC...
Patent Expiration Date : 2032-09-04
Patent Expiration Date : 2031-04-10
DASABUVIR SODIUM; OMBITASVIR, PARITAPREVIR, RITONAVIR
US Patent Number : 9044480
Drug Substance Claim :
Drug Product Claim :
Application Number : 206619
Patent Use Code : U-1638
Delist Requested :
Patent Use Description : TREATMENT OF HCV INFEC...
Patent Expiration Date : 2031-04-10
LOOKING FOR A SUPPLIER?
